Nitrates in different vascular beds, nitrate tolerance, and interactions with endothelial function.
The favorable anti-ischemic effect of nitrates is based on the unique distribution pattern of vascular relaxation that they evoke in different vascular sections. Nitrovasodilators reduce cardiac preload and wall tension, and thus myocardial oxygen consumption. They increase precollateral coronary perfusion pressure, thereby augmenting oxygen delivery to ischemic sections, especially to the subendocardial layers. These vasodilator actions are caused by the nitric oxide (NO)-induced activation of soluble guanylyl cyclase, which augments vascular cyclic guanosine monophosphate (cGMP) levels to suppress intracellular Ca2+ concentrations. After some metabolic steps NO is finally cleaved from all nitrovasodilators and is probably identical with, or very closely related to, endothelium-derived relaxing factor (EDRF). A dinitrosyl-iron complex may serve under biologic conditions to stabilize the NO- radical, which has an extremely short half-life. NO derived from nitrovasodilators is used therapeutically to substitute for a deficient endothelium-mediated vascular control and autacoid production.
Bassenge
E
E
Institute of Applied Physiology, Freiburg, Germany.
Zanzinger
J
J
D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects; D004361:Drug Tolerance; D004730:Endothelium, Vascular / Q000187:drug effects*; D006801:Humans; D009566:Nitrates / Q000378:metabolism / Q000494:pharmacology*; D009569:Nitric Oxide / Q000378:metabolism / Q000502:physiology; D014664:Vasodilation / Q000187:drug effects
D009566:Nitrates; D009569:Nitric Oxide